Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
The Journal of Cell Biology
|
January 19, 2011
ATR-mediated phosphorylation of DNA polymerase η is needed for efficient recovery from UV damage
Thomas Göhler, Simone Sabbioneda, Catherine M Green, et al.
DNA Repair
|
March 21, 2008
PTIP/Swift is required for efficient PCNA ubiquitination in response to DNA damage
Thomas Göhler, Ivan M Munoz, John Rouse, et al.
Nucleic Acids Research
|
February 22, 2005
Mutant p53 proteins bind DNA in a DNA structure-selective mode
Thomas Göhler, Stefan Jäger, Gabriele Warnecke, et al.
The Journal of Biological Chemistry
|
June 19, 2003
Analysis of p53 "latency" and "activation" by fluorescence correlation spectroscopy. Evidence for different modes of high affinity DNA binding
Julian Wölcke, Maurice Reimann, Martin Klumpp, et al.
The Journal of Biological Chemistry
|
August 13, 2002
Specific interaction of p53 with target binding sites is determined by DNA conformation and is regulated by the C-terminal domain
Thomas Göhler, Maurice Reimann, Dimitry Cherny, et al.
BMC Cancer
|
July 27, 2017
A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)
Thomas Decker, Friedrich Overkamp, Siegfried Rösel, et al.
Breast Cancer Research and Treatment
|
July 6, 2017
Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project
Hans-Jürgen Hurtz, Hans Tesch, Thomas Göhler, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 24, 2026
Effectiveness and safety of pegylated filgrastim (Pelgraz®) for the prevention of febrile neutropenia during cancer chemotherapy in all-day practice in Germany
Tilman Steinmetz, Peter Jungberg, Dagmar Guth, et al.
The Journal of Cell Biology
|
June 7, 2006
Excess Mcm2-7 license dormant origins of replication that can be used under conditions of replicative stress
Anna M Woodward, Thomas Göhler, M Gloria Luciani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2017
Sorafenib in Patients with Hepatocellular Carcinoma-Results of the Observational INSIGHT Study
Tom M Ganten, Rudolf E Stauber, Eckardt Schott, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
The Journal of Cell Biology
|
January 19, 2011
ATR-mediated phosphorylation of DNA polymerase η is needed for efficient recovery from UV damage
Thomas Göhler, Simone Sabbioneda, Catherine M Green, et al.
DNA Repair
|
March 21, 2008
PTIP/Swift is required for efficient PCNA ubiquitination in response to DNA damage
Thomas Göhler, Ivan M Munoz, John Rouse, et al.
Nucleic Acids Research
|
February 22, 2005
Mutant p53 proteins bind DNA in a DNA structure-selective mode
Thomas Göhler, Stefan Jäger, Gabriele Warnecke, et al.
The Journal of Biological Chemistry
|
June 19, 2003
Analysis of p53 "latency" and "activation" by fluorescence correlation spectroscopy. Evidence for different modes of high affinity DNA binding
Julian Wölcke, Maurice Reimann, Martin Klumpp, et al.
The Journal of Biological Chemistry
|
August 13, 2002
Specific interaction of p53 with target binding sites is determined by DNA conformation and is regulated by the C-terminal domain
Thomas Göhler, Maurice Reimann, Dimitry Cherny, et al.
BMC Cancer
|
July 27, 2017
A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)
Thomas Decker, Friedrich Overkamp, Siegfried Rösel, et al.
Breast Cancer Research and Treatment
|
July 6, 2017
Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project
Hans-Jürgen Hurtz, Hans Tesch, Thomas Göhler, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 24, 2026
Effectiveness and safety of pegylated filgrastim (Pelgraz®) for the prevention of febrile neutropenia during cancer chemotherapy in all-day practice in Germany
Tilman Steinmetz, Peter Jungberg, Dagmar Guth, et al.
The Journal of Cell Biology
|
June 7, 2006
Excess Mcm2-7 license dormant origins of replication that can be used under conditions of replicative stress
Anna M Woodward, Thomas Göhler, M Gloria Luciani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2017
Sorafenib in Patients with Hepatocellular Carcinoma-Results of the Observational INSIGHT Study
Tom M Ganten, Rudolf E Stauber, Eckardt Schott, et al.
Page
of 3